Biotech Defence’s Successful Submission of an Investigational New Drug (IND) Application for AccuTOX(R) as an Injectable Anticancer Treatment for Solid Tumors November 14, 2023
Biotech Defence Therapeutics Key Platform Patent Accepted Broadly Covering Vaccine Technology November 7, 2023
Featured News Defence’s Delivery of Encapsulated AccuTOX(TM)-Chitosan Nanoparticles Triggers Complete Tumor Regression in Animals with Pre-Established Solid Lymphoma October 17, 2023
Featured News Defence Announces Peer-reviewed Publication of Its Preclinical Data on Accum(R) as an Anti-Cancer Molecule in the Journal of Cancer Science October 10, 2023